HORIZONTAL PARTIAL LARYNGECTOMY FOR SUPRAGLOTTIC CANCER

1973 ◽  
Vol 1 (2) ◽  
pp. 53-55
Author(s):  
G. Patrick Bridger
1987 ◽  
Vol 101 (2) ◽  
pp. 143-154 ◽  
Author(s):  
H. J. Shaw

AbstractAttention is drawn to the problems of surgical resection by partial laryngectomy after full therapeutic dosage of telecobalt irradiation. Material is presented from two treatment centres to indicate trends in surgical treatment and the complications experienced. Results will be given which confirm a reasonable expectation of cure and functional conservation by vertical partial laryngectomy for recurrence of glottic cancer after irradiation. The results of treatment of recurrent supraglottic cancer by horizontal partial laryngectomy gave more cause for concern in terms of complications and survival. In conclusion an attempt is made, based on the quoted experience, to define the position of conservation surgery in two centres for laryngeal cancer in the United Kingdom.


1989 ◽  
Vol 98 (2) ◽  
pp. 125-129 ◽  
Author(s):  
Cynthia A. Spaulding ◽  
Paul A. Levine ◽  
William C. Constable ◽  
Robert W. Cantrell

This is a retrospective study of 33 patients with supraglottic cancer treated with partial laryngectomy and moderate-dose radiotherapy at the University of Virginia from 1967 through 1986. All patients had a 2-year minimum follow-up. Ten patients received preoperative radiotherapy, and 23, postoperative radiotherapy. The 2-year adjusted survival rate was impressive at 97%. Local control at 2 years was 96%, including one patient who was salvaged with total laryngectomy. Control of the neck was 90% at 2 years. Ninety percent of the patients alive at 2 years had a functional voice. One patient required a completion laryngectomy for chronic aspiration. Conservation surgery with radiotherapy provides excellent survival as well as locoregional control rates with preservation of function in selected patients with supraglottic cancer. This approach may be especially helpful in the management of bulky T2 lesions as well as T4 lesions with minimal vallecula or base of tongue involvement.


1996 ◽  
Vol 105 (11) ◽  
pp. 845-850 ◽  
Author(s):  
R. Theo Gregor ◽  
Augustinus A. M. Hart ◽  
Swi S. Oei ◽  
Alfons J. M. Balm ◽  
Frans J. M. Hilgers ◽  
...  

A retrospective review of patients from 1979 to 1988 was performed to assess the efficacy of neck dissection, prognostic factors, and the philosophy of treatment of me neck in supraglottic cancer. Of the 89 patients available for analysis, 26 were managed by horizontal partial laryngectomy (HPL), 44 by primary radiotherapy (RT), and 19 by total laryngectomy (TL). A total of 41 patients from the group had 63 neck dissections (NDs); 22 had bilateral and 19 unilateral dissections. A correlation of the pN with N staging revealed that when presenting with N2a nodes (>3 cm), one third had contralateral metastases, and with N2b (multiple), 100% had contralateral metastases. In multivariate analysis of the disease-free interval, age and staging emerged as independent prognostic variables. Although we observed no increased morbidity by dissecting the opposite side, our results did not support routine bilateral neck dissection in N0 patients. However, when the nodes are larger than 3 cm, or ipsilateral and multiple, bilateral neck dissection is recommended.


Cancers ◽  
2021 ◽  
Vol 13 (3) ◽  
pp. 568
Author(s):  
Gerhard Dyckhoff ◽  
Rolf Warta ◽  
Christel Herold-Mende ◽  
Elisabeth Rudolph ◽  
Peter K. Plinkert ◽  
...  

Supraglottic laryngeal cancer is characterized by poor prognosis. In contrast, excellent outcomes have been published in early-stage supraglottic cancers after laser surgery in single-institutional series in centers of excellence. Are these results reproducible in the normal clinical practice of less specialized facilities? As part of an observational cohort study, the outcomes of 194 supraglottic cancer patients were assessed after treatment by larynx-preserving surgery (transoral laser microsurgery [TLM] or open partial laryngectomy [OPL]) or total laryngectomy (TL), with each having risk-adopted adjuvant treatment, or primary (chemo-)radiotherapy (pCRT or pRT). In early-stage supraglottic cancers, TLM achieved a 5-year overall survival (5-year OS) of 62.0%. No significant survival difference could be discerned between patients with and without adjuvant treatment (HR 1.47; 95% CI: 0.80 2.69). The comparison between pCRT and pRT patients suggests that CRT is more effective in supraglottic cancer. The 5-year OS rate achieved in our multiinstitutional setting is comparable to that reached in laser surgery centers of excellence (59.4–76.0%). According to our data and supported by the literature, adjuvant RT (aRT) is not sufficiently effective in supraglottic cancers. In case adjuvant therapy is indicated, adjuvant chemoradiation (aCRT) could be recommended.


Author(s):  
Ji Heui Kim ◽  
Yoon Se Lee ◽  
Min Su Kwon ◽  
Jong-Lyel Roh ◽  
Seung-Ho Choi ◽  
...  

Author(s):  
Do Yang Park ◽  
Yong Cheol Koo ◽  
Jae Min Hong ◽  
Won Shik Kim ◽  
Yoon Woo Koh ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document